Trump Administration Issues Proposed Rule Allowing Importation; House Passes H.R. 3 Drug Pricing Bill on Party-Line Vote; AMCP Submits Letter to House on 21st Century Cures 2.0; Stephen Hahn, MD, Confirmed as New FDA Commissioner; FDA Issues Draft Guidance on Interchangeable Insulin
December 2019 News & Views: Read articles on CEO Blog: AMCP Defining Digital Therapeutics for Coverage, USC School of Pharmacy Wins AMCP Chapter of the Year Award, AMCP Foundation Honors Best Posters at Nexus 2019
Partnership Forum: This forum made recommendations and considerations for ways that benefit design and reimbursement may evolve without compromising patient access and care.
Increased simplicity, broader financial risk sharing, and an enhanced focus on patient care were among the recommendations developed by diverse stakeholders at a recent AMCP Partnership Forum focused on how to better manage the high costs of specialty medications.
In December 2016, AMCP applauded the passage of the 21st Century Cures Act as it included many provisions that will directly improve the health of Americans, from prompting new cures for cancer to combating opioid addiction.